Abu Dhabi-based Amea Power has entered into three contracts totaling USD 850 million with Chinese partners PowerChina and Mingyang Smart Energy. According to the Egyptian Cabinet, the agreements fund a 500 MW wind farm named Amunet 2 at Ras Shukeir on the Red Sea, valued at USD 650 million, and a USD 200 million wind turbine manufacturing facility in the Suez Canal Economic Zone (SCZone). PowerChina will build the wind farm, while Mingyang will supply 45 turbines of 11 MW capacity each. The turbine plant is projected to reach an annual capacity of 3 GW once both phases are operational by late 2029.
In healthcare, Abu Dhabi-based Arcera Life Sciences acquired exclusive international commercial rights to a Chinese diabetes therapy developed by Hong Kong-listed Innogen Pharma. Under the 15-year licensing pact potentially valued at more than USD 1 billion, Arcera will pay USD 15 million upfront, with near-term milestone payments reaching up to USD 38 million. The territory encompasses designated markets across the Middle East, Africa, Latin America, and Eastern Europe, including the UAE, subject to local regulatory approvals.
In transportation, Uber announced plans to deploy approximately AED 184 million over two years to expand its Dubai robotaxi operations utilizing vehicles sourced from Chinese partners, including WeRide and Apollo Go. According to the Dubai Media Office, driverless operations will expand from fixed pickup points to door-to-door services across Jumeirah and Umm Suqeim before entering Downtown Dubai, DIFC, and Business Bay. The UAE fleet is slated to approach 200 driverless vehicles by the end of the year.
Additionally, New Zealand infrastructure investor Morrison established an office at Abu Dhabi Global Market (ADGM) under a Category 4 license to advise on digital infrastructure, energy transition, and supply chain assets.
Sources
- Gulf Times · 2026-11-20



